List of works - Michael Proschan

A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection

scientific article

A meta-analysis of clinical studies conducted during the West Africa Ebola virus disease outbreak confirms the need for randomized control groups

scientific article published on 01 November 2019

A primer on strong vs weak control of familywise error rate

scientific article published on 27 February 2020

A randomized controlled safety/efficacy trial of therapeutic vaccination in HIV-infected individuals who initiated antiretroviral therapy early in infection.

scientific article

An open-label phase 1 clinical trial of the anti-α4β7 monoclonal antibody vedolizumab in HIV-infected individuals

scientific article published on 05 September 2019

Diagnosing fraudulent baseline data in clinical trials

scientific article published on 30 September 2020

Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption

scientific article

Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian children in the second year of life

scientific article

Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: a randomised, double-blind, placebo-controlled trial

scientific article

Evaluation of an antibody to α4β7 in the control of SIVmac239-nef-stop infection

scientific article published on 05 September 2019

Interleukin 7 reduces the levels of spontaneous apoptosis in CD4+ and CD8+ T cells from HIV-1-infected individuals

scholarly article

Kinetics of plasma HIV rebound in the era of modern antiretroviral therapy

scientific article published on 22 May 2020

Re-randomization tests in clinical trials

scientific article published on 22 January 2019

Sofosbuvir and ribavirin for hepatitis C genotype 1 in patients with unfavorable treatment characteristics: a randomized clinical trial

scientific article

Virologic response following combined ledipasvir and sofosbuvir administration in patients with HCV genotype 1 and HIV co-infection

scientific article published on March 2015

Virological response after 6 week triple-drug regimens for hepatitis C: a proof-of-concept phase 2A cohort study

scientific article published on 13 January 2015

List of works by Michael Proschan

A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection

A meta-analysis of clinical studies conducted during the West Africa Ebola virus disease outbreak confirms the need for randomized control groups

A primer on strong vs weak control of familywise error rate

A randomized controlled safety/efficacy trial of therapeutic vaccination in HIV-infected individuals who initiated antiretroviral therapy early in infection.

An open-label phase 1 clinical trial of the anti-α4β7 monoclonal antibody vedolizumab in HIV-infected individuals

Diagnosing fraudulent baseline data in clinical trials

Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption

Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian children in the second year of life

Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: a randomised, double-blind, placebo-controlled trial

Evaluation of an antibody to α4β7 in the control of SIVmac239-nef-stop infection

Interleukin 7 reduces the levels of spontaneous apoptosis in CD4+ and CD8+ T cells from HIV-1-infected individuals

Kinetics of plasma HIV rebound in the era of modern antiretroviral therapy

Re-randomization tests in clinical trials

Sofosbuvir and ribavirin for hepatitis C genotype 1 in patients with unfavorable treatment characteristics: a randomized clinical trial

Virologic response following combined ledipasvir and sofosbuvir administration in patients with HCV genotype 1 and HIV co-infection

Virological response after 6 week triple-drug regimens for hepatitis C: a proof-of-concept phase 2A cohort study